Entera Bio Corp (ENTX): Total Asset Value of Company

Graphic logo of enterabio.com (ENTX)

The price characteristics of Entera Bio Ltd. (ENTX) total assets, with a value of 19.57, highlight the biotech firm's dependence on external investments and FDA verdicts in developing oral protein delivery systems. The business relies on automated pill synthesis, where IT algorithms are supplemented by medical expertise. Future revenue is tied to B2B licensing of patented technologies for industry behemoths, as the company currently lacks market control.

Entera Bio (ENTX) Company Total Assets: for the period 07/04/2022 - 10/28/2026

Comprehensive metric breakdowns and analytics for enterabio.com (ENTX)

- price and consensus price forecast:
Share Price Entera Bio|ENTX - Price Target Chart
- market capitalization data:
Market Valuation ENTX|ENTX - Enterprise Value
- book capitalization data:
Accounting Value of a Share Entera Bio|ENTX - Book Capitalization|Market Capitalization to Book Value Ratio enterabio.com|ENTX - Aggregate Company Assets
- debt and liquidity data:
All Debt to Shareholders' Equity Ratio Entera Bio Ltd.|ENTX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Entera Bio|ENTX - Company Aggregate Debts|Debts to Book Capitalization ENTX|ENTX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Entera Bio
Fundamental valuation:ENTX, Entera Bio Corp
Finished products of Entera Bio Ltd

Retaining key peptide developers through stock option programs minimizes recruitment capital expenditures, which stabilizes the resource base of Entera Bio Ltd. (ENTX). The current trend of gross assets, reverse-calculated via return on assets (ROA), reflects the aggregate of assets and liabilities, allowing investors to assess the resilience of the company's balance sheet mass against inflationary costs on a daily planning horizon.

Competitors of Entera Bio Ltd. (ENTX)

HLN (haleon.com) - Total Business Assets|Aggregate Company Assets Kenvue KVUE|Total Asset Value of Company Verona Pharma PLC|Jyong Biotech Corp (MENS) - Company Total Assets|Aggregate Asset Value Ligand Corp (LGND)|Company Total Assets AMRX (Amneal Pharmaceuticals)|perrigo.com - Company Total Assets|Aggregate Company Assets Alvotech SA (ALVO)|LQDA: Aggregate Asset Value|GLPG (Galapagos Genomics) - Aggregate Company Assets|ANI Pharmaceuticals Corp (ANIP) - Cumulative Company Assets|MNKD (MannKind Corporation) - Company Total Assets|Company Total Assets amphastar.com (AMPH)|Pacira BioSciences, Inc. (PCRX) - Cumulative Company Assets|Aggregate Asset Value SPRY (ARS Pharmaceuticals Inc)|TBPH: Aggregate Company Assets|AQST - Company Assets|Cumulative Company Assets scPharma SCPH|TECX - Aggregate Business Assets|Company Total Assets Tonix Pharmaceuticals Holding Corp. TNXP|China SXT Pharmaceuticals, Inc. (SXTC) - Aggregate Asset Value|Company Total Assets EPRX (Eupraxia Pharmaceuticals, Inc.)|Company Assets BHST|eXoZymes Inc (EXOZ) - Aggregate Company Assets|Aggregate Asset Value oramed.com (ORMP)|HYFT: Company Total Assets|ABVC BioPharma Inc. - Company Assets|Cumberland Pharma (CPIX) - Aggregate Company Assets|Quantum BioPharma Corp (QNTM) - Total Business Assets|FGEN - Cumulative Company Assets|telomirpharma.com (TELO) - Aggregate Business Assets|Company Total Assets RANI (Rani Therapeutics Holdings)|Company Assets SNYR|Rallybio Corporation (RLYB) - Aggregate Company Assets|Aggregate Asset Value lexariabioscience.com (LEXX)|Company Total Assets PULM (Pulmatrix, Inc.)|PTHL - Company Total Assets|Cumulative Company Assets Aptorum (APM)|LYRA - Aggregate Asset Value|Impact BioMedical (IBO) - Company Total Assets|TNF Pharmaceuticals, Inc. (TNFA) - Aggregate Company Assets|YCBD: Company Total Assets|Company Total Asset Base PRFX|Altamira Therapeutics - Aggregate Company Assets|Company Assets Lipella Pharmaceuticals Inc LIPO|Cumulative Company Assets Optinose|Pieris Pharma - Aggregate Asset Value|PROC - Aggregate Company Assets|petrospharma.com (PTPI) - Aggregate Company Assets|QLI - Cumulative Company Assets|Acelyrin Inc. (SLRN) - Aggregate Business Assets|Company Total Assets TFF Pharma (TFFP)